Selective ghrelin receptor agonist (GHSR-1a). Stimulates pituitary GH secretion with high specificity, without significant activation of cortisol, acetylcholine, or prolactin pathways.
Studies have administered: 100–300mcg per administration, 1–3x daily in research literature
Animal and early human studies show significant GH pulse amplitude increase with favorable safety profile. Selectivity for GH without cortisol elevation distinguishes it from other GHRPs.
Mild water retention, transient growth hormone flush; generally considered cleanest GHRP in research
These compounds have been examined together in research literature. Combination use is not endorsed or recommended — this information is provided for research context only.
Want a Complete Research Monograph?
Our AI can generate a 2,000+ word deep-dive on Ipamorelin — including full clinical trial summaries, pharmacokinetics, and research frontiers.
Generate Deep Dive in Research Chat